wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35478921-C34CEC90-31F7-4A8C-A753-1E13CE92DC55
Q35478921-C34CEC90-31F7-4A8C-A753-1E13CE92DC55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35478921-C34CEC90-31F7-4A8C-A753-1E13CE92DC55
Suppression of basophil FcɛRI activation by serum from active chronic idiopathic/spontaneous urticaria (CIU/CSU) subjects
P2860
Q35478921-C34CEC90-31F7-4A8C-A753-1E13CE92DC55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35478921-C34CEC90-31F7-4A8C-A753-1E13CE92DC55
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a5322a85783f78d3127503f8ba11424bd58a9b90
P2860
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.